{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:33:17Z","timestamp":1793622797352,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nrleng.2026.501928","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:34:08Z","timestamp":1777116848000},"page":"501928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases"],"prefix":"10.1016","volume":"41","author":[{"given":"J.M.","family":"Garc\u00eda Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mar\u00eda Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Arrambide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carmen Calles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Castillo-Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Costa-Frossard Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Eichau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00c1.","family":"Hern\u00e1ndez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Landete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Meca Lallana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oreja-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mar\u00eda Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Caminero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.501928_bib0325","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.nrleng.2026.501928_bib0330","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.0000000000008319","article-title":"Head-to-head drug comparisons in multiple sclerosis: urgent action needed","volume":"93","author":"Tur","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501928_bib0335","doi-asserted-by":"crossref","first-page":"866092","DOI":"10.3389\/fimmu.2022.866092","article-title":"Biological markers in early multiple sclerosis: the paved way for radiologically isolated syndrome","volume":"13","author":"Rival","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0340","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/1352458519877810","article-title":"The long-term outcomes of CIS patients in the Barcelona inception cohort: looking back to recognize aggressive MS","volume":"26","author":"Tintore","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0345","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501928_bib0350","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain atrophy and lesion load predict long term disability in multiple sclerosis","volume":"84","author":"Popescu","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2026.501928_bib0355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0360","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250228","article-title":"Emerging imaging and liquid biomarkers in multiple sclerosis","volume":"53","author":"Gill","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0365","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/acn3.674","article-title":"Retinal measurements predict 10-year disability in multiple sclerosis","volume":"6","author":"Rothman","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","article-title":"Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis","volume":"15","author":"Rotstein","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0375","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1093\/brain\/awac220","article-title":"The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria","volume":"145","author":"Arrambide","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501928_bib0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0385","unstructured":"Recomendaciones diagn\u00f3sticas-terap\u00e9uticas de la SEN 2023. Manual de pr\u00e1ctica cl\u00ednica en esclerosis m\u00faltiple, NMO y MOGAD2023."},{"key":"10.1016\/j.nrleng.2026.501928_bib0390","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.26154","article-title":"Spinal fluid myeloid microvesicles predict disease course in multiple sclerosis","volume":"90","author":"Gelibter","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0395","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0400","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0405","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501928_bib0410","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1177\/1352458515623365","article-title":"Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity","volume":"22","author":"Kuhle","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0415","doi-asserted-by":"crossref","first-page":"912005","DOI":"10.3389\/fimmu.2022.912005","article-title":"Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis","volume":"13","author":"Kolliker Frers","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0420","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s40120-023-00535-z","article-title":"Neurofilament light chain in adult and pediatric multiple sclerosis: a promising biomarker to better characterize disease activity and personalize MS treatment","volume":"12","author":"Ghezzi","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nrleng.2026.501928_bib0425","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501928_bib0430","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77098-8","article-title":"Serum neurofilament light chain withstands delayed freezing and repeated thawing","volume":"10","author":"Altmann","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2026.501928_bib0435","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0440","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1515\/cclm-2023-0518","article-title":"Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury","volume":"62","author":"Wilson","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.nrleng.2026.501928_bib0445","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s00415-022-11507-y","article-title":"Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis","volume":"270","author":"Sen","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0450","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2026.501928_bib0455","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/13524585241237388","article-title":"Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: a 48-week prospective single-center study","volume":"30","author":"Johnsson","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0460","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nrleng.2026.501928_bib0470","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1177\/13524585221108080","article-title":"No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab","volume":"28","author":"Johnsson","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0475","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.26446","article-title":"Contributors to serum NfL levels in people without neurologic disease","volume":"92","author":"Fitzgerald","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0480","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120380","article-title":"Neurofilaments in neurologic disorders and beyond","volume":"441","author":"Mak","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2026.501928_bib0490","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2013 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0495","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501928_bib0500","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1177\/1352458519881428","article-title":"Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study","volume":"26","author":"Jakimovski","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0505","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0510","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.nrleng.2026.501928_bib0645","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/acn3.638","article-title":"Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis","volume":"5","author":"Chitnis","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0650","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501928_bib0525","doi-asserted-by":"crossref","first-page":"103535","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2026.501928_bib0530","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acn3.51060","article-title":"Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis","volume":"7","author":"Rosso","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0535","doi-asserted-by":"crossref","first-page":"e2120","DOI":"10.1212\/WNL.0000000000200258","article-title":"Blood neurofilament light in progressive multiple sclerosis: post hoc analysis of 2 randomized controlled trials","volume":"98","author":"Leppert","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501928_bib0540","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/acn3.51704","article-title":"Associations of sNfL with clinico-radiological measures in a large MS population","volume":"10","author":"Sotirchos","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0545","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2023.0010","article-title":"Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated with high-efficacy drugs","volume":"80","author":"Monreal","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0550","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/nmt-2017-0035","article-title":"Personalized medicine in multiple sclerosis","volume":"7","author":"Giovannoni","year":"2017","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.nrleng.2026.501928_bib0555","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1038\/s41598-021-88624-7","article-title":"Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment","volume":"11","author":"Walo-Delgado","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2026.501928_bib0560","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458517715132","article-title":"Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod","volume":"24","author":"Piehl","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501928_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104416","article-title":"Prognostic significance of neurofilament light in fingolimod therapy for multiple sclerosis: a systemic review and meta-analysis based on randomized control trials","volume":"69","author":"Ashkar","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2026.501928_bib0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nrleng.2026.501928_bib0575","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40120-022-00339-7","article-title":"Cladribine tablets for relapsing-remitting multiple sclerosis: a clinician's review","volume":"11","author":"Giovannoni","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nrleng.2026.501928_bib0580","doi-asserted-by":"crossref","first-page":"e1201","DOI":"10.1212\/WNL.0000000000009097","article-title":"Blood neurofilament light levels segregate treatment effects in multiple sclerosis","volume":"94","author":"Delcoigne","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501928_bib0585","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/acn3.795","article-title":"Blood neurofilament light as a potential endpoint in Phase 2 studies in MS","volume":"6","author":"Sormani","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0590","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1212\/NXI.0000000000001003","article-title":"Serum neurofilament levels and PML risk in patients with multiple sclerosis treated with natalizumab","volume":"8","author":"Fissolo","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.nrleng.2026.501928_bib0595","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.25437","article-title":"Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients","volume":"85","author":"Dalla Costa","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104893","article-title":"Serum neurofilaments are a reliable biomarker to early detect PML in multiple sclerosis patients","volume":"77","author":"Valentino","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2026.501928_bib0605","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac153","article-title":"Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers","volume":"4","author":"Brummer","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.nrleng.2026.501928_bib0610","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1212\/NXI.0000000000000856","article-title":"Long-term prognostic value of longitudinal measurements of blood neurofilament levels","volume":"7","author":"Haring","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.nrleng.2026.501928_bib0615","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2026.501928_bib0620","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2022-329020","article-title":"Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis","volume":"93","author":"Comabella","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2026.501928_bib0625","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis","volume":"80","author":"Meier","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0630","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"Radiologically isolated syndrome: 10-year risk estimate of a clinical event","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2026.501928_bib0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102807","article-title":"Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study","volume":"56","author":"Bittner","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nrleng.2026.501928_bib0640","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1212\/WNL.0000000000006902","article-title":"Prognostic value of serum neurofilaments in patients with clinically isolated syndromes","volume":"92","author":"Dalla Costa","year":"2019","journal-title":"Neurology"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:24:27Z","timestamp":1793622267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580826000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2173580826000350"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501928","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501928"}}